S1408 Incidence of Coccidioidomycosis Infections in Endemic Region Among Patients With Autoimmune Hepatitis

Abstract

Table 1. Reported Side effects of UDCA use Type Events (n) Frequency Gastrointestinal •F020Abdominal Pain (1) 2.5 % •F020Anal and Perianal Pain (4) 10% •F020Heartburn (1) 2.5 % •F020Constipation (3) 7.5 % •F020Diarrhea (2) 5 % •F020Bloating (1) 2.5 % •F020Flatulence (1) 2.5 % •F020Nausea (1) 2.5 % •F020Vomiting (1) 2.5 % •F020Dyspepsia (3) 7.5 % •F020Terminal ileum Ulceration (1) 2.5 % •F020Elevated AST and GGT (1) 2.5 % Neurologic •F020Dizziness (1) 2.5 % •F020Mood alteration (1) 2.5 % •F020Neuropathy, Carpal tunnel syndrome (1) 2.5 % Renal •F020Lower urinary tract symptom, Prostatism (1) 2.5 % Skin •F020Hair loss (1) 2.5 % •F020Skin Rash (2) 5% Hematology •F020Anemia (1) 2.5 % •F020Leukopenia (1) 2.5 % Auditory •F020Otitis (1) 2.5 % Infection •F020Dental Infection (1) 2.5 % •F020Skin Infection (1) 2.5 % •F020Gastroenteritis (1) 2.5 % Lymphatics •F020Lower Limbs edema (2) 5% Metabolic •F020Hypokalemia (1) 2.5 % Constitutional •F020Fatigue (2) 5 % •F020Insomnia (1) 2.5 % Malignancy •F020Basal cell carcinoma, nose (1) 2.5 % Total Events (n) % 40